Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk - US Preventive Services Task Force

Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk - US Preventive Services Task Force

Recommendation for Women at Increased Risk of Breast Cancer

A final recommendation statement and evidence summary on taking medication to reduce breast cancer risk is now available from the U.S. Preventive Services Task Force (USPSTF). The Task Force found that some women at increased risk of breast cancer can benefit from risk-reducing medications such as, tamoxifen, raloxifene, or aromatase inhibitors. However, women who are not at increased risk should not take these medications.